An increase in initial public offerings (IPOs) and a resulting uptick in market activity would provide pension funds with ...

In a report released today, Mark Massaro from BTIG reiterated a Buy rating on Guardant Health (GH – Research Report), with a price target of ...

Stifel raised the firm’s price target on Guardant Health (GH) to $53 from $45 and keeps a Buy rating on the shares. Q4 revenue beat ...

In February 2024, the domestic debt stood at GH¢275.8 billion but persistent borrowing on the treasury market has pushed it up. For government fiscal operations, the Central Bank could not ...

In this article, we are going to take a look at where Guardant Health, Inc. (NASDAQ:GH) stands against other best booming stocks to invest in now. The U.S. stock market closed on a downbeat on ...

Millions of Americans don't own any stocks. Buying even one share could drastically improve your finances. New research from The Motley Fool shows that just 62% of American adults invest in the ...

Guardant Health (NYSE:GH) reported fourth-quarter adjusted EPS loss of 62 cents, compared to a loss of 64 cents a year ago, ...

The Ghana Stock Exchange recorded a strong performance last year, with market capitalisation reaching GH¢111.36 billion by the end of 2024, according to the Bank of Ghana. At its recent Monetary ...

And as you add more money to it over the years, it can be broader and include more investments. Starting slow and learning about the stock market's sometimes erratic behaviors can be crucial to ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...